Life science professional responsibility in an age of dual-use research
PDF

Keywords

dual-use research

How to Cite

NOVOSSIOLOVA, T. and PERKINS, D. (2020) “Life science professional responsibility in an age of dual-use research”, One Health & Risk Management , 2(1), pp. 75-80. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/98 (Accessed: 20June2025).

Abstract

Biotechnology is progressing at an unprecedented pace promising to bring tremendous benefits by responding to health, socio-economic, and environmental challenges. At the same time, cutting-edge life science advances raise multifaceted social, legal, ethical, and security concerns, including the risk of accidental or deliberate misuse. Reconciling the expected benefits with potential risks requires effective governance of dual-use life science research. The US National Science Advisory Board for Biosecurity (NSABB), a consultative committee to the US Government defines ‘dual-use research’ as “the development of new technologies and the generation of information with the potential for benevolent and malevolent purposes” noting that “virtually all life sciences research has dual use potential”. Dual-use risk management needs to be multi-layered and flexible; regulation per se is not sufficient to capture the wide-ranging implications of cutting-edge life science advances. Fostering a shared understanding within the life science community of the risk that the life sciences could be misused in ways that cause harm to humans, animals, or plants is key. Life science stakeholders have a duty to be aware of the potential for misuse of scientific findings and of their obligation to help inform and shape critical policy decisions about biological security in the life sciences.

PDF

|Views: 228| |PDF Downloads: 155|


PDF

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370